MEET OUR
John Brown, PhD
Board Chairman
Senior Independent Director of BioCity and Acacia Pharma, and former Chairman of Cell and Gene Therapy Catapult and Synpromics.
Previous board roles include Chairman of Axis-Shield, Chairman of BTG, Non-executive Director of Vectura and Chief Executive Officer of Acambis.
David Venables, PhD
Chief Executive Officer
Former President of AskBio Europe, CEO at Synpromics, Anatara Lifesciences and Ark Therapeutics. Founding leadership team NightStar Therapeutics. Honorary Professor, Edinburgh University.
Elizabeth Klein, MBA
Board member
Investor Director, Calculus Capital. Board member, MIP Discovery. 20 years experience in life science investing. Founding team Klein-Edmonds Associates.
Gilad Gershon, MBA
Board member
CEO Tropic Biosciences. Experienced AgriTech entrepreneur and investor, who is deeply passionate about utilizing cutting-edge technologies in solving real world challenges.
Now you have met our Board of Directors, why not meet
To find out more about our technology and discuss partnering opportunities, please get in touch.
© 2024 Laverock Therapeutics - All rights reserved • Terms and Conditions • Privacy Policy